Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
H. Kang (Seoul, Republic of Korea), I. Kim (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea). Chronic intermittent hypoxia exacerbates lung fibrosis in bleomycin-induced lung injury mouse model. 428

Member's Comments

No comment yet.

Related content which might interest you: Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 The effect of pravastatin on bleomycin-induced lung injury and fibrosis in mouse Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Therapeutic hypercapnia prevents pulmonary hypertension in rats with bleomycin-induced chronic neonatal lung injury Source: Annual Congress 2011 - Resuscitation and ventilation in the baby and infant Year: 2011 Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation versus fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 396s Year: 2006 Sirtuin3 reduces acute lung inflammation and emphysematous aggravation in COPD exacerbation mouse model Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats Source: Eur Respir J 2001; 17: 1228-1235 Year: 2001 Oxidative stress and lung permeability during chlorine-induced acute lung injury in mice Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 The role of osteopontin in the pulmonary fibrosis caused by acute lung injury induced by lipopolysaccharide in rats Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 The role of pendrin in acute lung injury caused by ventilator-induced lung injury Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Rikkunshito ameliorates bleomycin-induced lung injury in mice Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 The effect of dexamethasone on the pulmonary fibrosis of acute lung injury induced by lipopolysaccharide in rats Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011 Thymosin beta4 protects mice from bleomycin-induced damage in the lung Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 KCa3.1 channel inhibition prevents fibrotic responses in a human lung explant model Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015